{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:07:26Z","timestamp":1760980046148},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1995,1,1]],"date-time":"1995-01-01T00:00:00Z","timestamp":788918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1995]]},"DOI":"10.1007\/bf00688326","type":"journal-article","created":{"date-parts":[[2004,11,28]],"date-time":"2004-11-28T17:25:14Z","timestamp":1101662714000},"page":"259-265","source":"Crossref","is-referenced-by-count":6,"title":["5-fluorouracil metabolism and cytotoxicity after pre-treatment with methotrexate or thymidine in human hypopharynx and colon carcinoma xenografts: a19F-nuclear magnetic resonance spectroscopy study in vivo"],"prefix":"10.1007","volume":"37","author":[{"given":"Robert","family":"Tausch-Treml","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Baumgart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Ziessow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"K\ufffdpf-Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"2081","volume":"42","author":"CM Benz","year":"1982","unstructured":"Benz CM, Tillis T, Tattelman E, Cadman E (1982) Optimal scheduling of methotrexate and 5-fluorouracil in human breast cancer. Cancer Res 42:2081","journal-title":"Cancer Res"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1016\/S0021-9258(19)43819-2","volume":"248","author":"G Bjursell","year":"1973","unstructured":"Bjursell G, Reichard P (1973) Effects of thymidine on deoxyribonucleotide triphosphate pools and deoxyribonucleic acid synthesis in Chinese hamster ovary cells. J Biol Chem 248:3904","journal-title":"J Biol Chem"},{"key":"CR3","first-page":"219","volume":"30","author":"D Bowen","year":"1978","unstructured":"Bowen D, White JC, Goldman JD (1978) A basis for pyrimidineinduced antagonism to methotrexate in Ehrlich ascites tumour cells in vitro. Cancer Res 30:219","journal-title":"Cancer Res"},{"key":"CR4","first-page":"219","volume":"38","author":"GP Browman","year":"1984","unstructured":"Browman GP (1984) Clinical applications of the concept of methotrexate plus 5-FU sequence-dependent ?synergy?. How good is the evidence? Cancer Treat Rep 38:219","journal-title":"Cancer Treat Rep"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0021-9258(19)69863-7","volume":"256","author":"E Cadman","year":"1981","unstructured":"Cadman E, Heimer R, Benz C (1981) The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells. J Biol Chem 256:1695","journal-title":"J Biol Chem"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0163-7258(89)90117-4","volume":"43","author":"LE Damon","year":"1981","unstructured":"Damon LE, Cadman E, Benz C (1981) Enhancement of 5-fluorouracil anti-tumor effects by the prior administration of methotrexate. Pharmacol Ther 43:155","journal-title":"Pharmacol Ther"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00178187","volume":"7","author":"JL Evelhoch","year":"1989","unstructured":"Evelhoch JL (1989) In vivo19F NMR spectroscopy: a potential monitor of 5-fluourouracil pharmacokinetics and metabolism. Invest New Drugs 7:5","journal-title":"Invest New Drugs"},{"key":"CR8","first-page":"180","volume-title":"Cancer chemotherapy: principles and practice","author":"JL Grem","year":"1990","unstructured":"Grem JL (1990) Fluorinated pyrimidines. In: Chabner V, Collins J (eds) Cancer chemotherapy: principles and practice. Lippincott, London, p 180"},{"key":"CR9","first-page":"1680","volume":"48","author":"WE Hull","year":"1988","unstructured":"Hull WE, Port RE, Herrman R, Britsch B, Kunz W (1988) Metabolites of 5-fluorouracil in plasma and urine as monitored by19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pre-treatment. Cancer Res 48:1680","journal-title":"Cancer Res"},{"key":"CR10","first-page":"1754","volume":"46","author":"M Keniry","year":"1986","unstructured":"Keniry M, Benz C, Shafer RH, James TL (1986) Noninvasive spectroscopic analysis of fluoropyrimidine metabolism in cultured tumor cells. Cancer Res 46:1754","journal-title":"Cancer Res"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/mrm.1910190111","volume":"19","author":"JA Koutcher","year":"1991","unstructured":"Koutcher JA, Sawyer RC, Kornblith AB, Stolfi RL, Martin DS, Devitt ML, Cowburn D, Young WY (1991) In vivo monitoring of changes in 5-fluorouracil metabolism induced by methotrexate measured by19F NMR spectroscopy. Magn Reson Med 19:113","journal-title":"Magn Reson Med"},{"key":"CR12","first-page":"179","volume":"69","author":"G Lynch","year":"1985","unstructured":"Lynch G, Kemeny N, Chun H, Martin D, Young C (1985) Phase I evaluation and pharmacokinetic study of weekly i. v. thymidine or 5-FU in patients with advanced colorectal carcinoma. Cancer Treat Rep 69:179","journal-title":"Cancer Treat Rep"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1200\/JCO.1988.6.10.1653","volume":"6","author":"MJW Pinedo","year":"1988","unstructured":"Pinedo MJW, Peters GFJ (1988) Fluorouracil: biochemistry and pharmacology. J Clin Oncol 6:1653","journal-title":"J Clin Oncol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/bjc.1989.275","volume":"60","author":"PMJ McSheehy","year":"1989","unstructured":"McSheehy PMJ, Prior MJW, Griffiths JR (1989) Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS in vivo. Br J Cancer 60:303","journal-title":"Br J Cancer"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/nbm.1940040605","volume":"4","author":"PMJ McSheehy","year":"1991","unstructured":"McSheehy PMJ, Maxwell RJ, Griffiths JR (1991) Detection of differential sensitivity to 5-fluorouracil in Ehrlich ascites tumour cells by19F NMR spectroscopy. NMR Biomed 4:274","journal-title":"NMR Biomed"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/bjc.1992.75","volume":"65","author":"PMJ McSheehy","year":"1992","unstructured":"McSheehy PMJ, Prior MJW, Griffiths JR (1992) Enhanced 5-fluorouracil cytotoxicity and elevated 5-fluoronucleotides in the rat Walker carcinosarcoma following methotrexate pre-treatment: a19F-MRS study in vivo. Br J Cancer 65:369","journal-title":"Br J Cancer"},{"key":"CR17","first-page":"5405","volume":"45","author":"FNM Naguib","year":"1985","unstructured":"Naguib FNM, Kouni MH el, Cha S (1985) Enzymes of uracil catabolism in normal and neoplastic human tissues. Cancer Res 45:5405","journal-title":"Cancer Res"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0304-4157(88)90002-0","volume":"947","author":"PGW Plagemann","year":"1988","unstructured":"Plagemann PGW, Wohlhueter RW, Woffendin C (1988) Nucleoside and nucleobase transport in animal cells. Biochim Biophys Acta 947:405","journal-title":"Biochim Biophys Acta"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0730-725X(92)90509-X","volume":"110","author":"PE Sijens","year":"1992","unstructured":"Sijens PE, Ng TC (1992) Thymidine modulated 5-fluorouracil metabolism in liver and RIF-1 tumors studied by19F magnetic resonance spectroscopy. Magn Reson Imaging 110:385","journal-title":"Magn Reson Imaging"},{"key":"CR20","first-page":"1384","volume":"51","author":"PE Sijens","year":"1991","unstructured":"Sijens PE, Huang Y, Baldwin NJ, Ng TC (1991)19F magnetic resonance spectroscopy studies of the metabolism of 5-fluorouracil in murine RIF-1 tumours and liver. Cancer Res 51:1384","journal-title":"Cancer Res"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/1097-0142(19800315)45:5+<1129::AID-CNCR2820451317>3.0.CO;2-I","volume":"45","author":"S Spiegelman","year":"1980","unstructured":"Spiegelman S, Nayak R, Sawer R, Stolfi R, Martin D (1980) Potentiation of the anti-tumor activity of 5-FU by thymidine and its correlation with the formation of (5FU)RNA. Cancer 45:1129","journal-title":"Cancer"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/bjc.1991.336","volume":"64","author":"R Tausch-Treml","year":"1991","unstructured":"Tausch-Treml R, K\u00f6pf-Maier P, Baumgart F, Gewiese B, Ziessow D, Scherer H, Wolf KJ (1991)31P nuclear magnetic resonance spectroscopy, histology and cytokinetics of a xenografted hypopharynx carcinoma following treatment with cisplatin: comparison of three sublines with increasing resistance. Br J Cancer 64:485","journal-title":"Br J Cancer"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/nbm.1940050305","volume":"5","author":"R Tausch-Treml","year":"1992","unstructured":"Tausch-Treml R, Baumgart B, Ziessow D, K\u00f6pf-Maier P (1992)31P NMR spectroscopy of a xenografted hypopharynx carcinoma: effects of tumour growth and treatment with cisplatin on the tumour phosphorus metabolism, histology and cytokinetics. NMR Biomed 5:127","journal-title":"NMR Biomed"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1073\/pnas.75.2.980","volume":"75","author":"B Ullman","year":"1978","unstructured":"Ullman B, Lee M, Martin DW, Santi DV (1978) Cytotoxicity of 5-fluoro-2-deoxuridine: requirement for reduced folate cofactors and antagonism by methotrexate. Proc Natl Acad Sci USA 75:980","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/1097-0142(19800315)45:5+<1135::AID-CNCR2820451318>3.0.CO;2-Q","volume":"45","author":"TM Woodcock","year":"1980","unstructured":"Woodcock TM, Martin DS, Damin LAM, Kemeny NE, Young CW (1980) Combination clinical trials with thymidine and 5-fluorouracil: a phase I and clinical pharmacological evaluation. Cancer 45:1135","journal-title":"Cancer"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00688326.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00688326\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00688326","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T23:43:30Z","timestamp":1625010210000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00688326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995]]}},"alternative-id":["BF00688326"],"URL":"https:\/\/doi.org\/10.1007\/bf00688326","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995]]}}}